Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-10 | Ultragenyx Pharmaceutical Inc. | Horn Howard
(Chief Financial Officer) |
S | Common Stock | D | 7465 | $52.76 - $52.76 | $393,853 |
| 2024-09-16 | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore...
(SVP, Chief Accounting Officer) |
A | Common Stock | A | 700 | $0.00 - $0.00 | $0 |
| 2024-08-06 | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D
(President & CEO) |
S | Common Stock | D | 20000 | $50.17 - $50.17 | $1,003,400 |
| 2024-07-02 | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (...
(Director) |
S | Common Stock | D | 584 | $40.98 - $40.98 | $23,932 |
| 2024-06-18 | Ultragenyx Pharmaceutical Inc. | Dunsire Deborah
(Director) |
A | Common Stock | A | 5345 | $0.00 - $0.00 | $0 |
| 2024-06-18 | Ultragenyx Pharmaceutical Inc. | Fust Matthew K
(Director) |
A | Common Stock | A | 5345 | $0.00 - $0.00 | $0 |
| 2024-06-18 | Ultragenyx Pharmaceutical Inc. | WELCH DANIEL G
(Director) |
A | Common Stock | A | 5345 | $0.00 - $0.00 | $0 |
| 2024-06-18 | Ultragenyx Pharmaceutical Inc. | NARACHI MICHAEL
(Director) |
A | Common Stock | A | 5345 | $0.00 - $0.00 | $0 |
| 2024-06-18 | Ultragenyx Pharmaceutical Inc. | Ray Amrit
(Director) |
A | Common Stock | A | 5345 | $0.00 - $0.00 | $0 |
| 2024-06-18 | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (...
(Director) |
A | Common Stock | A | 5345 | $0.00 - $0.00 | $0 |
| 2024-06-18 | Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ
(Director) |
A | Common Stock | A | 5345 | $0.00 - $0.00 | $0 |
| 2024-06-12 | Ultragenyx Pharmaceutical Inc. | Parschauer Karah ...
(EVP and Chief Legal Officer) |
S | Common Stock | D | 9806 | $45.00 - $45.00 | $441,270 |
| 2024-06-10 | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (...
(Director) |
S | Common Stock | D | 1737 | $41.10 - $41.10 | $71,390 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |